Clinical Trials Directory

Trials / Unknown

UnknownNCT05549739

Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Hacettepe University · Academic / Other
Sex
All
Age
41 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate respiratory parameters and functional capacity in coronary artery patients.

Detailed description

Decreased pulmonary function as measured by forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), or peak expiratory flow (PEF) has been associated with an increased risk of cardiovascular mortality and morbidity. A low MIP value may generally indicate weak muscle strength and therefore be an indicator of general poor health. Respiratory muscle weakness and decreased respiratory muscle endurance affect exercise tolerance in individuals with chronic disease, including cardiovascular disease. Studies have supported the association of grip strength with frailty, physical activity, diabetes, functional limitation, nutritional status, metabolic syndrome, and mortality. The study will evaluate respiratory parameters and functional capacity in coronary artery patients.

Conditions

Timeline

Start date
2022-09-23
Primary completion
2022-11-01
Completion
2022-11-01
First posted
2022-09-22
Last updated
2022-10-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05549739. Inclusion in this directory is not an endorsement.